Guest guest Posted July 5, 2011 Report Share Posted July 5, 2011 News 9 new results for hepatitis c Medco's Specialty Pharmacy Improves Hepatitis C Patient Outcomes, Drives Down ...PR Newswire (press release)The Hepatitis C Therapeutic Resource Center at Accredo has been successful in helping patients, physicians and payers with this difficult therapeutic regimen. Accredo's approach is to maximize clinical effectiveness for patients and benefits plan ....See all stories on this topic » Hepatitis C cases in region on the riseWausau Daily HeraldFederal, state and local health officials are trying to figure out why the number of hepatitis C cases in six central and northern Wisconsin counties has increased. The Centers for Disease Control and Prevention and state Department of Health Services ...See all stories on this topic » Trial drug helps Decatur man overcome Hepatitis CChampionHepatitis C was “the missing piece of the puzzle†that explained Quinton 's weight loss and fatigue. A routine blood test to refill a prescription revealed abnormal liver function. Upon further examination, his doctor found that was in the ...See all stories on this topic » Ipswich: Court's decision to lock up hepatitis C spit woman welcomedEast Anglian Daily TimesBy COLIN ADWENT, crime correspondent Tuesday, July 5, 2011 IPSWICH: Ambulance staff today applauded a court's decision to lock up a woman with hepatitis C after she spat blood at a paramedic and cut his arm. To send a link to this page to a friend, ...See all stories on this topic » East Anglian Daily Times Pharmasset climbs as analyst raises targetForbesAP , 07.05.11, 12:23 PM EDT NEW YORK -- Shares of hepatitis C drug developer Pharmasset Inc. rose Tuesday after a Canaccord Genuity analyst raised his price target on the stock. THE SPARK: Analyst Farmer assumed coverage of the stock, ...See all stories on this topic » Study identifies genetic variant linked to development of liver cancer in ...pharmabiz.comA genome-wide study by researchers at the RIKEN Centre for Genomic Medicine, Hiroshima University Hospital and Sapporo-Kosei General Hospital has identified a genetic variant associated with the development of liver cancer in chronic hepatitis C virus ...See all stories on this topic » Biotech Posts Strong Second Quarter Gain, Burrill Report FindsMarketwire (press release)Vertex Pharmaceuticals is also moving quickly to build on its recent success in obtaining FDA approval for telaprevir, its potential blockbuster drug to treat hepatitis C, now known as Incivek. The company has inked a licensing agreement with Alios ...See all stories on this topic » People with HIV regret bias by medical staffDAWN.comThey said since most of them also had hepatitis C they wanted the government to provide all relevant facilities, including free-of-cost diagnostic and treatment services for HIV and hepatitis C, at one place. “None of us is receiving treatment for ...See all stories on this topic » DAWN.com Movers roundup: Peabody Energy, MedtronicForbes_ Shares of Zalicus Inc. traded higher after an Oppenheimer & Co. analyst started covering the stock with an "Outperform" rating. _ Shares of hepatitis C drug developer Pharmasset Inc. rose after a Canaccord Genuity analyst raised his price target on ...See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.